Skip to main content

Table 1 Summarized study schedule at each visit in the clinical trial

From: Evaluation of pharmacodynamic properties and safety of Cinnamomum zeylanicum (Ceylon cinnamon) in healthy adults: a phase I clinical trial

 

Visit 0 (screening visit)

Visit 1 (1 month)

Visit 2 (2 months)

Visit 3 (3 month)

Medical history taking

•

•

•

•

FBG

•

•

•

•

Lipid profilea

•

  

•

Liver functionb

•

•

•

•

Renal functionc

•

•

•

•

FBCd

•

  

•

Blood pressure

•

•

•

•

Physical examinatione

•

•

•

•

Urinanalysisf

•

  

•

  1. atotal cholesterol, triglyceride, HDL cholesterol; bAST, ALT, total bilirubin, PT/INR; ccreatinine; dWBC, RBC, hemoglobin (HGB), hematocrit (HCT), platelet count (PLT); ebody weight (kg), height (cm), waist circumference (cm), hip circumference (cm), waist:hip ratio; fUrine microscopy, urine for sugar and protein